• As FDA door shuts on its PI3K, MEI Pharma throws in the towel, lays off staff

    1 month ago - By San Diego Biotechnology

    Having steered a PI3K inhibitor from preclinical studies all the way to Phase II, San Diego's MEI Pharma is all but washing its hands of the drug as the FDA raises the bar on the...
    Read more ...